Calbryte Ca Ion Indicator

Lab Reagents

Aat Bioquest Laboratories manufactures the calbryte ca ion indicator reagents distributed by Genprice. The Calbryte Ca Ion Indicator reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact AAT Bioquest. Other Calbryte products are available in stock. Specificity: Calbryte Category: Ca Group: Ion Indicator

Ion Indicator information

Calbryte™ 520, potassium salt

20658 10x50 ug
EUR 471.6

Calbryte™ 590, potassium salt

20706 5x50 ug
EUR 367.2

Calbryte™ 590, potassium salt

20707 1 mg
EUR 842.4

Calbryte™ 630, potassium salt

20727 5x50 ug
EUR 367.2

Autoclave Indicator Tapes,19mm (3/4")

LC3018-001 roll
EUR 84

Autoclave Circle Indicator Labels,1/2"

LC3019-001 5000/roll
EUR 313.2

CA/ Rat CA ELISA Kit

ELA-E0875r 96 Tests
EUR 1063.2

CA 074

A1926-1 1 mg
EUR 177.6
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-10 10 mg
EUR 582
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-25 25 mg
EUR 895.2
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-5 5 mg
EUR 373.2
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-5.1 10 mM (in 1mL DMSO)
EUR 518.4
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-S Evaluation Sample
EUR 97.2
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA-1001

B2669-25 25mg
EUR 709.2

CA-1001

B2669-5 5mg
EUR 223.2

CA-074

B2971-1 1 mg
EUR 235.2

CA-074

B2971-5 5 mg
EUR 764.4